Sign In  |  Register  

DOI: 10.1208/s12249-010-9486-9Pages: 1147-1151

Evaluation of a Nanoemulsion-Based Formulation for Respiratory Delivery of Budesonide by Nebulizers

1. School of Pharmacy, University of Bradford, Institute of Pharmaceutical Innovation

2. Tehran University of Medical Sciences, Department of Medical Nanotechnology, School of Advanced Medical Nanotechnology

3. University of Huddersfield, School of Applied Sciences

Correspondence to:
Amir Amani
Tel: +98-2188991119
Fax: +98-2188991119
Email: aamani@sina.tums.ac.ir

Close

Abstract

The aim of this work was to evaluate the in vitro performance of a nebulized nanoemulsion formulation which had been optimised previously. To do so, a transparent nanoemulsion preparation containing 1.5 mg/ml of budesonide was prepared and diluted to achieve concentrations of 250 and 500 μg/ml budesonide. The in vitro characteristics of the diluted nanoemulsions were then compared with the commercially available suspension of budesonide (Pulmicort Respules®) when nebulized using a jet and a vibrating mesh nebulizer. A smaller MMAD with improved aerosol output was observed in the nanoemulsion preparations compared with the corresponding suspension formulations indicating an improved in vitro performance for the nanoemulsion-based preparations.

This article is freely available, click here to access the full text/PDF

2189 Views

  • Accepted: Jun 30, 2010
  • Online: Jul 24, 2010

Article Tools

aaps journal